By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cognoptix 

20 Main Street

Acton   Massachusetts  01720  U.S.A.
Phone: 978-263-0005 Fax: 978-263-0015


SEARCH JOBS


Industry
Diagnostics






Company News
Cognoptix President And CEO Paul Hartung Tells Neurotech Investors: "Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care." 4/25/2014 9:54:45 AM
Cognoptix President And CEO Paul Hartung Tells Analysts: “Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care.” 4/2/2014 7:42:27 AM
Cognoptix Eye Test Generates Robust Results in Clinical Study to Identify Alzheimer’s Disease 2/14/2014 9:51:08 AM
Cognoptix President And CEO Paul Hartung Named "Emerging Medical Technologies Innovator Of The Month" By Life Science Intelligence® 12/5/2013 8:03:53 AM
Cognoptix Eye Test Shows Impressive Results In Clinical Study To Identify Alzheimer’s Disease: 85% Sensitivity And 95% Specificity 11/15/2013 9:26:47 AM
Inventages Portfolio Company, Cognoptix, Demonstrates the Ability to Accurately Identify Alzheimer's Disease 10/4/2013 9:00:27 AM
Clinical Investigators Comment on Their Study of Cognoptix Eye Test Designed to Identify Alzheimer's Disease That Showed Strong Results: 85% Sensitivity and 95% Specificity 9/30/2013 11:20:01 AM
Company Profile for Cognoptix 9/27/2013 9:28:53 AM
Cognoptix Eye Test Designed to Identify Alzheimer’s Disease Shows Strong Results: 85% Sensitivity and 95% Specificity 9/23/2013 12:45:00 PM
Cognoptix Advisory: Can Alzheimer's Be Detected a Decade Earlier? 8/19/2013 9:55:38 AM
//-->